| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ATHEROSCLEROSIS.2005.02.026 |
| P698 | PubMed publication ID | 16216595 |
| P50 | author | Outi Närvänen | Q125255620 |
| Seppo Ylä-Herttuala | Q11893052 | ||
| P2093 | author name string | Arja T Erkkilä | |
| Seppo Lehto | |||
| Matti I J Uusitupa | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 157-162 | |
| P577 | publication date | 2005-04-14 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease | |
| P478 | volume | 183 |
| Q47623831 | A role for autoantibodies in atherogenesis |
| Q37709623 | Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases |
| Q37824302 | Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases |
| Q36381096 | Biomarkers of obesity and subsequent cardiovascular events |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q38591312 | Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome. |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q36572982 | Natural antibodies, autoantibodies and complement activation in tissue injury |
| Q47911686 | Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients. |
| Q51641936 | Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids. |
| Q37275296 | The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. |
Search more.